Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of TMC278 in Healthy Japanese Males
NCT01804244Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2013
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rilpivirine in human immunodeficiency virus infection (HIV), sponsored by Janssen Pharmaceutical. Started Mar 2013; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01804244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01804244.